Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors.
about
Pharmacology of hallucinations: several mechanisms for one single symptom?Ketamine and other glutamate receptor modulators for depression in adultsParaneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratomaAntiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus ErythematosusAntibodies as Mediators of Brain PathologyA model for lupus brain diseaseAnti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus ErythematosusMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusBrain Correlates of Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI)The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus.Gene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody productionEffects of prolonged treatment with memantine in the MRL model of CNS lupus.Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.Antibodies and brain disease: a convergence of immunology and physiology.Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.Antibodies and the Brain: Lessons from Lupus.Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institutionNeurologic manifestations of systemic lupus erythematosus in children and adults.Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trialHuman lupus autoantibodies against NMDA receptors mediate cognitive impairment.Brain-reactive antibodies and disease.Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.Neuropsychological patterns in systemic lupus erythematosus patients with depression.Autoimmune channelopathies.Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosusNeuroimmunopathology in a murine model of neuropsychiatric lupusAutoimmune and paraneoplastic channelopathies.Genetic contributions to the autoantibody profile in a rabbit model of Systemic Lupus Erythematosus (SLE).Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.Neuropsychiatric Systemic Lupus Erythematosus: A Diagnostic Conundrum
P2860
Q21284720-2872A538-A972-48A4-8794-D5ADA3FCE6E9Q24186746-42974ED1-2458-4244-A735-F19CA48F016EQ24653500-DA2E3CDC-0D61-402D-AAED-0221A6F32394Q26766428-E5965BD1-ED05-451E-9A8F-A36F2DE53A7AQ26780374-FF6EE7B2-2468-41AA-A2E9-D9B7C75745D8Q26824461-43A0A8F8-CB32-4465-BC27-E45CC5A09324Q26996498-E8CED642-A827-4F9C-920F-9EAFC6302341Q28075974-43CD1310-4579-4FF9-A3FA-A30AEBB187AAQ28268802-80C38957-6B3C-470D-AC2F-BCC839D5B999Q29048637-63781288-C541-467B-BD7A-F059D158C87CQ30476952-C802ED1A-56AF-4F84-833F-961E198A2948Q30485404-1BB8B650-7E9E-4276-87CF-EFD4B52463DAQ30496834-C7318545-1A55-496C-AC06-D6D4EBCF9142Q30612050-3C5430B6-8BC8-43E8-B7F8-346DB5E9F3DEQ30727936-3F806B27-08AC-4DB2-9BEE-7DBABE2C297AQ33267001-89CB95C0-BEFE-48C8-829F-DA7DE1D6A0E6Q33723529-CA71F771-C721-4C07-B5B0-D0898915FEFDQ34059923-97B4201A-498C-49A2-9116-C89B34A21C6CQ34201906-BEA1B978-BDF7-4B64-B19A-45EAC5E8B530Q34276891-742CAF8B-4739-4B0E-8359-A8AA965609BAQ34307491-514C8F2F-18A3-44FD-8FF6-B2D3BC024280Q34310715-A61D84B8-B1A4-4395-B03C-697DC05EC546Q34550430-2024E96B-1670-44C8-90A5-A9E1E2A3169BQ34632695-7F4B0BCD-9404-426A-93CF-96F3D6A77AA0Q34753885-63068571-5261-4B98-8D24-F56211F7E4FBQ35129267-9BB830C9-99FD-4B3B-8937-4FFDD1B28CF9Q35156885-84D6FA60-8CD3-41F2-9E9B-F10D26D5B8B9Q35225108-6C739322-1D67-44FD-8938-62DB0F5A7ED3Q35458567-D7A8E518-B74D-47EE-88E5-82AB8472031DQ36294377-08197FC3-99E6-4759-A059-13692A3445E1Q36307423-FC182D73-FC33-4D21-BFF8-5FD72159EC9FQ36332517-ED381F22-E13C-4499-B11B-5E580E199B94Q36392300-51430E98-6DE9-4E48-BB78-D63C9F9D46E6Q36577209-048714A0-69A8-42B8-B071-FF0A2AEB64A5Q36632385-894E6C15-D243-4BF6-BDF1-842DAFADA31DQ36707992-61093AD1-BCBA-4CC9-986F-9A523E7C2EB1Q36774744-A14B264A-0B04-42B2-8286-0C10DE8E84C0Q36923999-25A592D6-95B1-44CF-B76A-1C115CAA2403Q37203376-AAFD35BC-C76F-4C99-8CDB-2F5E980F4DF0Q37233978-DA43A7CD-FB86-43C0-87A9-C21174D806D2
P2860
Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@ast
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@en
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@nl
type
label
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@ast
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@en
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@nl
prefLabel
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@ast
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@en
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@nl
P2093
P2860
P1476
Neuropsychiatric disturbances ...... bodies against NMDA receptors.
@en
P2093
K Waterloo
S I Mellgren
W Koldingsnes
P2860
P304
P356
10.1111/J.1468-1331.2004.00976.X
P577
2005-05-01T00:00:00Z